Related Experiment Video
Updated: Mar 26, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
MicroRNA-497 inhibits cell proliferation, migration, and invasion by targeting AMOT in human osteosarcoma cells
Wen-Dong Ruan1, Pei Wang1, Shiqing Feng1
1Department of Orthopedics, Tianjin Medical University General Hospital, Heping District, Tianjin, People's Republic of China.
Abstract:
MicroRNAs (miRNAs) have a role in the development and progression of human malignancy. The expression of miR-497 is decreased in malignant tumors, which suggests a role for miR-497 as a tumor suppressor. Angiomotin is encoded by the AMOT gene, which is a target for miR-497. Angiomotin has a role in angiogenesis, cell proliferation, and invasion in human malignancies, including osteosarcoma. However, the role of miR-497 in human osteosarcoma is unknown. This preliminary study included human osteosarcoma tissues and normal tissues from 20 patients, the osteosarcoma cell lines, MG-63, SAOS-2, U-2 OS, and the human osteoblast cell line hFOB (OB3). Western blots for angiomotin and quantitative real-time polymerase chain reaction for the expression of miR-497 and AMOT were performed. Knockdown studies were performed using RNA interference and transfection studies used miR-497 mimics. Quantitative cell migration assays were performed, and cell apoptosis was studied by flow cytometry. Osteosarcoma cells and cell lines showed reduced expression of miR-497 and increased expression of angiomotin. Transfection of osteosarcoma cells with miR-497 mimics suppressed the expression of angiomotin. Results from a dual-luciferase reporter system supported AMOT as a direct target gene of miR-497. Knockdown of AMOT using RNA interference resulted in inhibition of osteosarcoma cell proliferation, migration, and invasion. These preliminary studies support a role for miR-497 as a suppressor of AMOT gene expression in human osteosarcoma cells, resulting in suppression of tumor cell proliferation and invasion. Further studies are recommended to investigate the role of miR-497 in osteosarcoma and other malignant mesenchymal tumors.
Insights
MicroRNA-497 (miR-497) acts as a tumor suppressor in osteosarcoma by inhibiting angiomotin (AMOT) expression. Lower miR-497 levels correlate with increased AMOT, promoting cancer cell proliferation and invasion.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are crucial regulators in human cancer development.
- Reduced miR-497 expression is observed in various malignancies, suggesting a tumor-suppressive role.
- Angiomotin (AMOT), involved in cell proliferation and invasion, is a target of miR-497.
Purpose of the Study:
- To investigate the role of miR-497 in human osteosarcoma.
- To determine if miR-497 targets the AMOT gene in osteosarcoma cells.
- To assess the impact of miR-497 and AMOT on osteosarcoma cell behavior.
Main Methods:
- Analysis of miR-497 and AMOT expression in osteosarcoma tissues and cell lines.
- Western blot and quantitative real-time polymerase chain reaction (qRT-PCR) for expression analysis.
- RNA interference for AMOT knockdown and miR-497 mimics for transfection, followed by cell migration and apoptosis assays.
Main Results:
- Osteosarcoma tissues and cell lines exhibited decreased miR-497 and increased AMOT expression.
- miR-497 mimics transfection suppressed AMOT expression, confirming AMOT as a direct target.
- AMOT knockdown inhibited osteosarcoma cell proliferation, migration, and invasion.
Conclusions:
- miR-497 functions as a tumor suppressor in osteosarcoma by directly inhibiting AMOT expression.
- This inhibition leads to reduced tumor cell proliferation and invasion.
- Further research is warranted to explore miR-497's role in osteosarcoma and other mesenchymal tumors.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

